Hematopoietic stem cell transplantation (HSCT) is associated with physical and psychological symptoms that can negatively affect quality of life. In a single-center randomized clinical trial that enrolled 160 adult patients with hematologic malignancies who were undergoing HSCT, El-Jawahri and colleagues assessed the effect of an inpatient palliative care intervention—focused on management of physical and psychological symptoms—on patient quality of life during hospitalization for HSCT. The authors report that compared with standard care, use of inpatient palliative care resulted in a smaller decrease in quality of life after 2 weeks. In an Editorial, Malani and Widera discuss integrating palliative care with potentially curative therapy among patients with serious illness.
Highlights. JAMA. 2016;316(20):2059-2061. doi:10.1001/jama.2015.14601